Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Genomic sequencing was performed to identify GBA-related Parkinson's disease patients, and five clones of iPS cells from 6 patients were generated by plasmid methods. Genome editing by CRISPR/cas9 was employed to edit GBA gene (L444), but its efficiency was about 10%, and it was lower than expected, even in HEK 293 cells. To overcome the disadvantages from heterogeneity of genetic background in iPS research, we are analyzing the corin-sorted dopaminergic precursor cells, as well as increasing the number of target clones.
|